DR. HANDELSMAN, MD
Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE
Medical Director & Principal Investigator, Metabolic Institute of America
Dr. Yehuda Handelsman is the medical director and principal investigator of the Metabolic Institute of America and an endocrinologist in solo private practice in Tarzana, California, where he developed and successfully utilizes a comprehensive, multiple interventional approach to preventing and managing diabetes, obesity, Lipid Disorders and cardiovascular disease. A Master of the American College of Endocrinology and a Fellow of the American Society of Preventive Cardiology, American College of Physicians and National Lipid Association, he has been listed repeatedly in “Top Doctors of Los Angeles”, “Southern California Super Doctors,” “America’s Best Physicians” and “Best Doctors of America”.
He is chair of the AACE task force of the 2019 Lipid management Algorithm to Prevent cardiovascular disease, member, AACE/ACE 2020 Task Force to Update the Comprehensive Diabetes Management Algorithm and the 2020 AACE/ACE Combined Guidelines for CGM & Pumps. A member of the AACE Lipid & CV Health, Diabetes & Obesity Disease networks. Past president of the American College of Endocrinology (ACE) & of the American Association of Clinical Endocrinologists (AACE) and the Pacific Lipid Association; and a past member, Board of Directors, American Association for Preventive Cardiology. He is chair & program director of the annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease; Chair & Program director, The Heart in Diabetes- initiative and Medical Congress; Chair & Founder the International Lipid Forum and the International Committee for Insulin Resistance; senior scientific consultant for the Metabolic Endocrine Education Foundation.
A nationally and internationally recognized expert Handelsman has researched, lectured, and published extensively on diabetes its comprehensive treatment and complications, CHF, the prevention of Kidney disease and cardiovascular disease; controlling obesity, Lipid Disorders, HTN, insulin resistance, PCOS, prediabetes and Cardio-metabolic disorders. He has also consulted and lectured on multi-hormonal obesity, diabetes & cancer, whole body Glucose homeostasis, lipodystrophy, thyroid and osteoporosis. He published over 130 peer reviewed original research & review papers, position and consensus statements, editorials, clinical practice guidelines, books’ chapters and his Book “Clinical Management of Cardiovascular Risk in Diabetes and Obesity” is Published by Professional Communications, Inc.
Chair Task Force & Writing committee Co-Chair- AACE 2017 Lipid Guideline; Chair the AACE 2011 & 2015 Comprehensive Diabetes Guidelines; member of the AACE 2013-20 Comprehensive Diabetes Algorithms.. An associate editor of the Journal of Diabetes, Member editorial panel of “European Medical Journal - Diabetes”, Editorial Advisory Board “Clinical Endocrinology News” and Editorial Board - “Endocrine Today” and editorial advisory panel of “Treatment Strategies – Diabetes” of the Cambridge Research center, United Kingdom. Dr. Handelsman frequently serves as guest editor and reviewer for multiple publications, such as the Journal of Clinical Hypertension, Metabolic Syndrome and Related Disorders, Diabetes and Vascular Disease Research, Postgraduate Medicine, Endocrine Practice, and Diabetes Care among others. He Co-Chaired the consensuses on SGLT2i & DKA, Diabetes, Obesity & Cancer, Insulin resistance Syndrome, Lipodystrophy- Clinical approach and Pre-Diabetes-Clinical Impact. He has been chair, member, co-author, and reviewer of many AACE/ACE guidelines, algorithms & position statements including Obesity, Glucose monitors, Continuous Glucose Monitors and HTN.
Handelsman is a member of the American College of Endocrinology, American Association of clinical Endocrinologists, American Diabetes Association, National Lipid Association, the Obesity Society, American Association for Preventive Cardiology, International Atherosclrosis Society, National Osteoporosis Foundation, American Thyroid Association, Academy of Thyroidologists, American College of Physicians, European Association for the Study of Diabetes, Los Angeles & California Medical Associations, and the American Medical Association.
Dr. Handelsman is a Summa Cum Laude graduate of the University of the Pacific, in Stockton, California. He earned his doctor of medicine degree from Tel Aviv University Sackler Faculty of Medicine in Israel. He completed a subsequent internship and residency in internal medicine at New York Infirmary Beekman Downtown Hospital under the supervision of New York University. His fellowship in diabetes and endocrinology was conducted at the University of Southern California Medical School in Los Angeles.
For Dr. Handelsman's full CV, please click: